Quality Management 2017

The experience of National Cancer Institute of Milano

The experience of the Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 2005-2012: 2260 MD clinics (consultations, second opinions) • Improved application of diagnostic/therapeutic guide-lines - partial or inappropriate therapeutic indications for patients examined in MD clinics (vs NCCN/EAU): 59% - wrong prescriptions (vs NCCN/EAU): 11% • Histologic reclassification (from low to intermediate risk class): 8% • Improved accrual in Active Surveillance protocols • Better identification of patients to be enrolled in clinical trials • High patients satisfaction

theoric score: 7.5